Cargando…

Gli(ko) BMSC: A potential strategy of treatment for renal fibrosis

OBJECTIVE: There are many researches on using bone marrow mesenchymal stem cells (BMSCs) in the treatment of acute kidney injury (AKI), which has certain effects, but the mechanism of action is still unclear. Previous researches show that glioma-associated oncogene homolog 1 (Gli 1) can promote the...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Long, Gao, Xiang, Bi, Yue, Li, Meng, Sun, Huanhuan, Tian, Xiaochao, Bi, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society for Regenerative Medicine 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111922/
https://www.ncbi.nlm.nih.gov/pubmed/35620638
http://dx.doi.org/10.1016/j.reth.2022.04.001
_version_ 1784709317227708416
author Shi, Long
Gao, Xiang
Bi, Yue
Li, Meng
Sun, Huanhuan
Tian, Xiaochao
Bi, Wei
author_facet Shi, Long
Gao, Xiang
Bi, Yue
Li, Meng
Sun, Huanhuan
Tian, Xiaochao
Bi, Wei
author_sort Shi, Long
collection PubMed
description OBJECTIVE: There are many researches on using bone marrow mesenchymal stem cells (BMSCs) in the treatment of acute kidney injury (AKI), which has certain effects, but the mechanism of action is still unclear. Previous researches show that glioma-associated oncogene homolog 1 (Gli 1) can promote the proliferation and migration of cells, which can also promote renal fibrosis. Therefore, we investigate the influence of Gli-regulated BMSCs on repairing AKI and renal fibrosis induced by limb Ischemia-Reperfusion (I/R). METHODS: The Crispr-Cas9 technique was adopted to knock out the Gli1 gene from the mouse BMSCs according to green fluorescent tracing, and the BMSCs (BMSCs-Gli(ko)) with Gli1 gene knocked out and the BMSCs as control group were obtained. The cell proliferation, apoptosis, cycle and SHH signal pathway gene level were tested. The mice were built to the AKI model with inducing I/R injury, then the BMSCs-Gli(ko) and BMSCs cells were injected into the mice, and their IL-1, IL-1B, TNF-a, serum creatinine (Scr) and blood urea nitrogen (BUN) levels were tested; Western blot was employed to test the expression of α-SMA, SMAD2 and SMAD4 in the renal tissues of mice. Finally, flow cytometry was used to test the content of BMSCs containing green fluorescence in the blood of mice. RESULTS: The BMSCs-Gli(ko) containing green fluorescence and the mouse AKI model were built; both BMSCs and BMSCs-Gli(ko) can reduce the damage level, and BMSCs-Gli(ko) outperformed BMSCs in protecting renal tubules and anti-fibrosis. Our study also shows that BMSCs-Gli(ko) stayed longer in the blood of mice, which might also be one of the reasons why BMSCs-Gli(ko) outperformed BMSCs in preventing renal tubules and fibrosis. To sum it up, could be key target of using.
format Online
Article
Text
id pubmed-9111922
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Japanese Society for Regenerative Medicine
record_format MEDLINE/PubMed
spelling pubmed-91119222022-05-25 Gli(ko) BMSC: A potential strategy of treatment for renal fibrosis Shi, Long Gao, Xiang Bi, Yue Li, Meng Sun, Huanhuan Tian, Xiaochao Bi, Wei Regen Ther Original Article OBJECTIVE: There are many researches on using bone marrow mesenchymal stem cells (BMSCs) in the treatment of acute kidney injury (AKI), which has certain effects, but the mechanism of action is still unclear. Previous researches show that glioma-associated oncogene homolog 1 (Gli 1) can promote the proliferation and migration of cells, which can also promote renal fibrosis. Therefore, we investigate the influence of Gli-regulated BMSCs on repairing AKI and renal fibrosis induced by limb Ischemia-Reperfusion (I/R). METHODS: The Crispr-Cas9 technique was adopted to knock out the Gli1 gene from the mouse BMSCs according to green fluorescent tracing, and the BMSCs (BMSCs-Gli(ko)) with Gli1 gene knocked out and the BMSCs as control group were obtained. The cell proliferation, apoptosis, cycle and SHH signal pathway gene level were tested. The mice were built to the AKI model with inducing I/R injury, then the BMSCs-Gli(ko) and BMSCs cells were injected into the mice, and their IL-1, IL-1B, TNF-a, serum creatinine (Scr) and blood urea nitrogen (BUN) levels were tested; Western blot was employed to test the expression of α-SMA, SMAD2 and SMAD4 in the renal tissues of mice. Finally, flow cytometry was used to test the content of BMSCs containing green fluorescence in the blood of mice. RESULTS: The BMSCs-Gli(ko) containing green fluorescence and the mouse AKI model were built; both BMSCs and BMSCs-Gli(ko) can reduce the damage level, and BMSCs-Gli(ko) outperformed BMSCs in protecting renal tubules and anti-fibrosis. Our study also shows that BMSCs-Gli(ko) stayed longer in the blood of mice, which might also be one of the reasons why BMSCs-Gli(ko) outperformed BMSCs in preventing renal tubules and fibrosis. To sum it up, could be key target of using. Japanese Society for Regenerative Medicine 2022-05-12 /pmc/articles/PMC9111922/ /pubmed/35620638 http://dx.doi.org/10.1016/j.reth.2022.04.001 Text en © 2022 The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Shi, Long
Gao, Xiang
Bi, Yue
Li, Meng
Sun, Huanhuan
Tian, Xiaochao
Bi, Wei
Gli(ko) BMSC: A potential strategy of treatment for renal fibrosis
title Gli(ko) BMSC: A potential strategy of treatment for renal fibrosis
title_full Gli(ko) BMSC: A potential strategy of treatment for renal fibrosis
title_fullStr Gli(ko) BMSC: A potential strategy of treatment for renal fibrosis
title_full_unstemmed Gli(ko) BMSC: A potential strategy of treatment for renal fibrosis
title_short Gli(ko) BMSC: A potential strategy of treatment for renal fibrosis
title_sort gli(ko) bmsc: a potential strategy of treatment for renal fibrosis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111922/
https://www.ncbi.nlm.nih.gov/pubmed/35620638
http://dx.doi.org/10.1016/j.reth.2022.04.001
work_keys_str_mv AT shilong glikobmscapotentialstrategyoftreatmentforrenalfibrosis
AT gaoxiang glikobmscapotentialstrategyoftreatmentforrenalfibrosis
AT biyue glikobmscapotentialstrategyoftreatmentforrenalfibrosis
AT limeng glikobmscapotentialstrategyoftreatmentforrenalfibrosis
AT sunhuanhuan glikobmscapotentialstrategyoftreatmentforrenalfibrosis
AT tianxiaochao glikobmscapotentialstrategyoftreatmentforrenalfibrosis
AT biwei glikobmscapotentialstrategyoftreatmentforrenalfibrosis